Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
J Heart Lung Transplant. 2010 Mar;29(3):240-6. doi: 10.1016/j.healun.2009.06.027. Epub 2009 Nov 22.
Despite 20 years of lung transplantation (LTx), factors influencing long-term survival remain largely unknown. The United Network for Organ Sharing (UNOS) data set provides an opportunity to examine long-term LTx survivors.
We conducted a case-control study embedded within the prospectively collected UNOS LTx cohort to identify 836 adults from 1987 to 1997 who survived >or=10 years after first LTx. LTx patients within the same era and surviving 1 to 5 years served as controls. Multivariable logistic regression with incorporation of spline terms evaluated the odds of being a 10-year survivor. Two separate models were constructed. Model A incorporated pre-operative, operative, and donor-specific factors. Model B incorporated the factors used in Model A with post-operative covariates. Additional outcomes evaluated included hospitalizations for infection, rejection, and bronchiolitis obliterans.
Of 4,818 LTx patients from 1987 to 1997, 836 (17.3%) survived >or=10 years with a mean follow-up of 148.8 +/- 21.6 months. Mean follow-up for 1,657 controls was 34.0 +/- 13.9 months. The distribution of 10-year survivors by disease was cystic fibrosis, 170 (20%); chronic obstructive pulmonary disease, 254 (30%); and idiopathic pulmonary fibrosis, 92 (11%). On multivariable logistic regression, significant factors influencing 10-year survival included age <or=35 years (odds ratio [OR] 1.07, 95% confidence interval [CI], 1.03-1.11; p = 0.01), bilateral LTx (OR. 1.71; 95% CI, 1.25-2.34; p = 0.001), and hospitalizations for infections (OR, 1.40; 95% CI, 1.27-1.54; p < 0.001) and for rejection (OR, 0.55; 95% CI, 0.48-0.65; p < 0.001).
Examination of a cohort of long-term LTx survivors in the UNOS data set indicates that bilateral LTx and fewer hospitalizations for rejection may portend improved long-term survival after LTx.
尽管肺移植(LTx)已有 20 年的历史,但影响长期生存的因素仍很大程度上未知。美国器官共享联合网络(UNOS)数据集提供了一个检查长期 LTx 存活者的机会。
我们进行了一项病例对照研究,该研究嵌入在 UNOS LTx 队列中,该队列前瞻性地收集了 1987 年至 1997 年间的 836 名成年人,这些成年人在首次 LTx 后存活了> = 10 年。同一时期存活 1 至 5 年的 LTx 患者作为对照。使用包含样条项的多变量逻辑回归评估成为 10 年存活者的可能性。构建了两个单独的模型。模型 A 纳入了术前、手术和供体特异性因素。模型 B 纳入了模型 A 中使用的因素以及术后协变量。评估的其他结果包括感染、排斥和闭塞性细支气管炎的住院治疗。
在 1987 年至 1997 年间接受 LTx 的 4818 名患者中,836 名(17.3%)存活> = 10 年,平均随访 148.8 +/- 21.6 个月。1657 名对照者的平均随访时间为 34.0 +/- 13.9 个月。10 年存活者的疾病分布为囊性纤维化,170 例(20%);慢性阻塞性肺疾病,254 例(30%);特发性肺纤维化,92 例(11%)。多变量逻辑回归显示,影响 10 年生存率的显著因素包括年龄<=35 岁(比值比[OR] 1.07,95%置信区间[CI],1.03-1.11;p = 0.01)、双侧 LTx(OR 1.71;95% CI,1.25-2.34;p = 0.001)和感染(OR 1.40;95% CI,1.27-1.54;p < 0.001)和排斥(OR 0.55;95% CI,0.48-0.65;p < 0.001)住院。
对 UNOS 数据集中长期 LTx 存活者队列的检查表明,双侧 LTx 和较少的排斥住院治疗可能预示着 LTx 后长期生存的改善。